66643-1-Ig

antibody from Proteintech Group

Targeting: ANLN ANILLIN, scra, Scraps

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

66643-1-Ig

Provider

Proteintech Group

Product name

ANLN antibody

Antibody type

Monoclonal

Description

KD/KO validated ANLN antibody (Cat. #66643-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1B4A8

Vial size

20ul, 150ul

References

Submitted references

Vasculogenic mimicry-associated novel gene signature predicted prognosis and response to immunotherapy in lung adenocarcinoma.

Zhang L, Wu J, Yin WW, Hu J, Liao L, Ma J, Xu Z, Wu S
Pathology, research and practice 2024 Jan;253:155048

---

ANLN Promotes the Proliferation and Migration of Gallbladder Cancer Cells via STRA6-Mediated Activation of PI3K/AKT Signaling.

Zhu X, Zhang Y, Bian R, Zhu J, Shi W, Ye Y
Cancers 2024 Feb 11;16(4)

---

CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.

Li L, Huang K, Zhao H, Chen B, Ye Q, Yue J
Cell cycle (Georgetown, Tex.) 2020 May;19(10):1236-1252

---

LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN.

Zhang M, Wang F, Xiang Z, Huang T, Zhou WB
Clinical and experimental pharmacology & physiology 2020 Aug;47(8):1464-1472

---

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.

Dai X, Mei Y, Chen X, Cai D
Frontiers in genetics 2019;10:790